NCT00303524 - Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients | Biotech Hunter

Enrollment

170

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

February 28, 2009

Conditions

Breast Cancer

Interventions

DRUG

Goserelin acetate

Injection 3.6 mg monthly

DRUG

Goserelin acetate

injection 10.8 mg every 3 months

Trial Locations (22)

Research Site, Chiba

Research Site, Fukuoka

Research Site, Fukushima

Research Site, Isehara

Research Site, Kagoshima

Research Site, Kashiwa

Research Site, Kawasaki

Research Site, Kitakyushu

Research Site, Kumamoto

Research Site, Matsuyama

Research Site, Miyazaki

Research Site, Nagoya

Research Site, Niigata

Research Site, Osaka

Research Site, Ōta-ku

Research Site, Saitama

Research Site, Sayama

Research Site, Shimotsuke

Research Site, Suita

Research Site, Tokorozawa

Research Site, Tokyo

Research Site, Utsunomiya